EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Curcumin Analog J7 Attenuates Liver Fibrosis and Metabolic Dysregulation in a Rat Model of Type 2 Diabetes via Modulation of TGF-β/Smad and NF-κB/BCL-2/BAX Pathways

Jun Ma iD, Wei Chen, Deep K Vaishnani iD, Congying Wang, Shuman Xue, Qiuqin Yang iD, Yuheng Tong, Ningjia Lei, Zhichao Zhao, Furong Ying

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s511372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Jun Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People's Republic of China. Hauptthemen laut MEDLINE: Curcumin, Diabetes Mellitus, Type 2, Liver Cirrhosis, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminDiabetes Mellitus, Type 2Liver CirrhosisDiabetes Mellitus, ExperimentalAnimalsRatsProto-Oncogene Proteins c-bcl-2MaleNF-kappa BRats, Sprague-Dawleybcl-2-Associated X ProteinSmad ProteinsSignal TransductionTransforming Growth Factor betaDisease Models, AnimalDose-Response Relationship, DrugTransforming Growth Factor beta1Structure-Activity Relationship

Stichwörter der Autor:innen

MAFLDNF-κB-BCL-2/BAX axisTGF-β/Smad signaling pathwaycurcumin analoginsulin resistanceliver fibrosismetabolic dysfunction-associated fatty liver disease

Substanzen

CurcuminProto-Oncogene Proteins c-bcl-2NF-kappa Bbcl-2-Associated X ProteinSmad ProteinsTransforming Growth Factor betaTransforming Growth Factor beta1Bax protein, rat

Autor:innen und Institutionen

  • Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People's Republic of China.
  • Renji College, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, People's Republic of China.
  • School of International Studies, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, People's Republic of China.
  • School of Clinical Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, People's Republic of China.
  • Pharmacy College, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, People's Republic of China.
  • Department of Critical Care Medicine, Yuyao People's Hospital, Yuyao, Zhejiang, 315400, People's Republic of China.

ORCID-Profile: Jun Ma, Deep K Vaishnani, Qiuqin Yang

Zitieren

APA

Ma, J., Chen, W., Vaishnani, D. K., Wang, C., Xue, S., Yang, Q., Tong, Y., Lei, N., Zhao, Z., & Ying, F. (2025). Curcumin Analog J7 Attenuates Liver Fibrosis and Metabolic Dysregulation in a Rat Model of Type 2 Diabetes via Modulation of TGF-β/Smad and NF-κB/BCL-2/BAX Pathways. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s511372

Vancouver

Ma J, Chen W, Vaishnani DK, Wang C, Xue S, Yang Q, et al. Curcumin Analog J7 Attenuates Liver Fibrosis and Metabolic Dysregulation in a Rat Model of Type 2 Diabetes via Modulation of TGF-β/Smad and NF-κB/BCL-2/BAX Pathways. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s511372

BibTeX
@article{Ma2025,
  author = {Ma, Jun and Chen, Wei and Vaishnani, Deep K and Wang, Congying and Xue, Shuman and Yang, Qiuqin and Tong, Yuheng and Lei, Ningjia and Zhao, Zhichao and Ying, Furong},
  title = {Curcumin Analog J7 Attenuates Liver Fibrosis and Metabolic Dysregulation in a Rat Model of Type 2 Diabetes via Modulation of TGF-β/Smad and NF-κB/BCL-2/BAX Pathways},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s511372}
}
Kostenlos starten →